Biosimilars Unveiled: Current Trends, Challenges, and Future Opportunities in the US Marketplace : Episode 10
Opinion
Video
Out of Pocket Costs Associated with Biosimilar Use
The panel discusses out of pocket costs and the impact of the 340b program for various patient types.
EP: 1.Biologics Utilization Impacting US Health Care Spending
EP: 2.Current Landscape of Biosimilar Use in US Healthcare Space
EP: 3.Interchangeability Impacting Biosimilar Uptake
EP: 4.The Impact of Payer Coverage and Reimbursement on Biosimilars
EP: 5.Navigating Biosimilar Uptake in New Patients
EP: 6.Economic Impacts and Pricing Strategies Surrounding Biosimilars
EP: 7.Private Label Biosimilars
EP: 8.Biosimilars in the Commercial Sector
EP: 9.The Influence of Employer Preferences And Adoption of Biosimilars
Now Viewing
EP: 10.Out of Pocket Costs Associated with Biosimilar Use
EP: 11.Unmet Needs and Future Initiatives
EP: 12.Ideal Goals for Biosimilar Utilization
EP: 13.Foreseeable Biosimilar Trends
EP: 14.Legislative Support for Biosimilars
EP: 15.Key Takeaways for Biosimilar Utilization
Related Videos
Related Content
